http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3028030

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Randomized Controlled Trial
endingPage 38
issn 1532-2149
1090-3801
issueIdentifier 1
pageRange 33-38
publicationName European journal of pain (London, England)
startingPage 33
bibliographicCitation Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain. 2005 Feb;9(1):33–8. doi: 10.1016/j.ejpain.2004.03.003. PMID: 15629872.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739a66694da23e0e1fcf1d9f370255cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3bb0eb9eeb9ba12d1f54c6df15e88ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cf11dd5ab5a568a5be9815965ca7c0f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d77a8368e70a8602144da33b5fa62db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2b188e063a2929c9f4754f2fa3fbf10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96626ea5725c162b0f426b5fc10e7e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78fb6c36b24020f59075925133982c0b
date 200502
identifier https://pubmed.ncbi.nlm.nih.gov/15629872
https://doi.org/10.1016/j.ejpain.2004.03.003
isPartOf https://portal.issn.org/resource/ISSN/1090-3801
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21642
https://portal.issn.org/resource/ISSN/1532-2149
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder
discusses http://id.nlm.nih.gov/mesh/M0019683
http://id.nlm.nih.gov/mesh/M0028095
http://id.nlm.nih.gov/mesh/M0001067
http://id.nlm.nih.gov/mesh/M0014072
http://id.nlm.nih.gov/mesh/M0014964
http://id.nlm.nih.gov/mesh/M0026372
http://id.nlm.nih.gov/mesh/M0201546
http://id.nlm.nih.gov/mesh/M0023529
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015283Q000008
http://id.nlm.nih.gov/mesh/D009025Q000008
http://id.nlm.nih.gov/mesh/D013001Q000188
http://id.nlm.nih.gov/mesh/D002490Q000187
http://id.nlm.nih.gov/mesh/D000700Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D018759Q000009
http://id.nlm.nih.gov/mesh/D010147
http://id.nlm.nih.gov/mesh/D004351Q000502
http://id.nlm.nih.gov/mesh/D017367Q000009
http://id.nlm.nih.gov/mesh/D000077593
http://id.nlm.nih.gov/mesh/D017367Q000008
http://id.nlm.nih.gov/mesh/D012701Q000378
http://id.nlm.nih.gov/mesh/D002490Q000503
http://id.nlm.nih.gov/mesh/D018759Q000008
http://id.nlm.nih.gov/mesh/D009638Q000378
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D013001Q000503
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D015283Q000009
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D013001Q000523
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D004351Q000187
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D009025Q000009
http://id.nlm.nih.gov/mesh/D000700Q000009
http://id.nlm.nih.gov/mesh/D003866Q000209
http://id.nlm.nih.gov/mesh/D003866Q000188
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127151
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9258

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135730525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129626560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530

Total number of triples: 77.